PHN/ PLPHN0000014 /
| 16/07/2024 16:47:54 | Chg. -0.30 | Volume | Bid16:59:05 | Ask16:59:05 | High | Low |
|---|---|---|---|---|---|---|
| 11.00PLN | -2.65% | 2,509 Turnover: 27,700.05 |
11.00Bid Size: 152 | 11.20Ask Size: 569 | 11.30 | 11.00 |
GlobeNewswire
07/01
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generat...
GlobeNewswire
03/10/2023
Rita And Alex Hillman Foundation Doubles Funding For Early-Stage, Nursing-Driven Innovations
GlobeNewswire
12/09/2023
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) ...
GlobeNewswire
12/09/2023
Sorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate...
GlobeNewswire
07/09/2023
Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) f...
GlobeNewswire
15/08/2023
Velatura HIE Corporation and Premier Health Network Announce Launch of CareConvene in Georgia
Newsfile Corp
17/01/2023
Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3...
Newsfile Corp
21/09/2022
Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day ...
Newsfile Corp
07/07/2022
Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day P...
GlobeNewswire
22/03/2022
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan
GlobeNewswire
20/03/2022
Sorrento Reports Promising Results With a Universal Chimeric mRNA COVID-19 Vaccine That Elicits Pote...
GlobeNewswire
17/03/2022
Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., to Become Public...
GlobeNewswire
09/03/2022
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th
GlobeNewswire
02/03/2022
Sorrento Announces COVISHIELD (STI-9199) Antibody Nasal Drops Prevent Productive SARS-CoV-2 Infectio...
GlobeNewswire
02/03/2022
Sorrento Announces FDA Authorization to Proceed With Phase 1 Study Of Intranasal STI-9199 (COVISHIEL...
GlobeNewswire
02/03/2022
NX Development Corp. (NXDC) Names Salvatore DeSena, M.D., as Chief Executive Officer
GlobeNewswire
28/02/2022
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Cli...
GlobeNewswire
17/02/2022
Sorrento Announces That It Has Acquired a Majority Ownership in Diagnostic Manufacturer Zhengzhou Fo...
GlobeNewswire
14/02/2022
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022
GlobeNewswire
07/02/2022
Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call
